Contact Us


Mayne Pharma Announces Strategic investment in US Facilities

Metrics Contract Services Announces Serialization Capabilities at Greenville Site

Metrics announces successful qualification of two commercial bottling lines for serialization at its new US$80 million oral solid dose commercial manufacturing site.

Metrics Adds Commercial Gerteis Roller Compaction Capabilities

Metrics has added a Gerteis Mini-Pactor® roller compactor to its granulation capabilities at its new US$80 million oral solid dose commercial manufacturing facility in Greenville, North Carolina. 

Our Continued Focus on FTIM and Phase I Services

For over 20 years, Metrics’ pharmaceutical development services have been growing, offering expanding capacities, capabilities, and manufacturing processes for small molecule oral solid dosage forms. And through it all, Metrics continues to invest in equipment and resources to support a healthy foundation of business in the First-time-in-Man and Phase I space.

Take a Look at Our New $80-Million Oral Solid Dose Manufacturing Facility

With the added capacity of this new 126,000-square-foot facility our development clients can keep their projects in one contiguous location under one site registration. Watch our video and see for yourself.

Sample Submission Request Form

Sending a sample to Metrics? Use this form to record your sample, storage and testing information...

Upcoming Events

Metrics is excited to share our upcoming events calendar. Connect with us at a meeting or conference in 2018 to learn more about our new offerings and what they mean for your next project.

Metrics Contract Services Appoints Associate Director of Pharmaceutical Development

Metrics Contract Services, the contract pharmaceutical development and manufacturing division of Mayne Pharma, has appointed Yogesh D. Sadhale, Ph.D., as associate director of pharmaceutical development.

Dissolution is King

In his article recently published by Contract Pharma, Keith Moore, Vice President of Analytical Services at Metrics Contract Services,  discusses why dissolution testing deserves closer attention and stronger emphasis in the pharmaceutical industry for defining the performance of a drug and ensuring product quality.